期刊文献+

用重组纯化M_2抗原检测抗线粒体抗体M_2在原发性胆汁性肝硬化诊断中的意义

下载PDF
导出
摘要 原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)是一种由免疫介导的慢性进展性疾病,以血清自身抗体和肝内汇管区细胞浸润为特征,主要表现为肝内小胆管进行性破坏与门静脉炎症性改变。高滴度的抗线粒体抗体(anti-mitoc hondrial antibody,AMA)为PBC血清学诊断标志。
出处 《中国药物与临床》 CAS 2012年第2期177-179,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献10

  • 1姜小华,仲人前,孔宪涛.原发性胆汁性肝硬化发病机制研究进展[J].中国免疫学杂志,2002,18(8):586-589. 被引量:19
  • 2Koizumi H,Onozuka Y,Shibata M,et al.Positive rate of antimi-tochondrial antibody in Japanese corporate workers.Rinsho By-ori,2000,48(10):966-970.
  • 3Homberg JC,Stelly N,Andreis I,et al.A new anti-mitochondrial antibody(anti-M6) in iproniazid-induced hepatitis.Clin Exp Immunol,1982,47:93-102.
  • 4Miyakawa et al.Detection of antimitochondrial autoantibodies in immunofluorescent AMA-Negative patients with primary biliary cirrhosis using recombinant autoantigens.Hepatology,2001,34:243-248.
  • 5Joplin RE,Neuberger JM.Immunopalhology of primary biliary cirrhosis.Eur J Gastroenterol,1999,10:587-593.
  • 6Nakano T,lnoue K,H irohara J,et al.Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a2PBC).Hepa-tol Rest2002,22(2):250-260.
  • 7Miyakawa H,Tanaka A.Kikuchi K,et al.Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant au-toantigens.Hepatology,2001,34(2):243-248.
  • 8Uddenfeldt P,Danielsson A,Forssell A,et al.Features of Sjfi-gren's syndrome in patients with primary biliary cirrhosis.J Intern Med,1991,230.443.
  • 9Tsuneyama K,Vande-Water J,Yamazaki K,et al.Primary biliary cirrhosis an epithelitis:evidence of abnormal salivary gland im-munohistochemistry.Autoimmunity,1997,26:23.
  • 10Lindgren S,Manthorpe R,Eriksson S.Autoimmune liver disease in patients with primary Sjogren's syndrome.J Hepatol,1994,20:354.

二级参考文献18

  • 1[1]Tanaka A, Borchers A T, Ishibashi H et al. Genetic and familial consider ations of primary biliary cirrhosis [ J ]. Am J Gastroenterol, 2001; 96 ( 1 ): 8
  • 2[2]Kim W R, Lindor K D, Locke G R et al. Epidemiology and natural history of primary biliary cirrhosis in a US community[J]. Gastroenterology, 2000; 119(6): 1631
  • 3[3]Miyakawa H, Tanaka A, Kikuchi K et al. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis[J]. Hepatology, 2001; 34 (2) :243
  • 4[4]Joplin R E, Neuberger J. Immunopathology of primary biliary cirrhosis [J]. Eur J Gastroenterol Hepatol, 1999; 11 (6) :587
  • 5[5]Metcalf J V,Mitchison H C,Palmer J et al. Natural history of early pri mary biliary cirrhosis[J]. Lancet, 1996;348(8): 1399
  • 6[6]Koizumi H, Onozuka Y, Shibata M et al. Positive rate of anti-mitochondri al antibody in Japanese corporate workers[J]. Rinsho Byori, 2000; 48 (10) :966
  • 7[7]Jones D E J, Palmer J M, Kirby J A et al. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy[J]. Liver, 2000;20( 1 ): 351
  • 8[8]Ahmed A F, Ohtani H, Nio M et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis[J] .J Pathol,2001; 193(3) :383
  • 9[9]Harada K, Ozaki S, Gershwin M E et al. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis [J]. Hepatology, 1997; 26 (6): 1399
  • 10[10]Sekiya H, Komats T,lsono E et al. Decrease in the prevalence of IL-4producing CD4+ T cells in patients with advanced stage of primary biliarycirrhosis[J]. Am J Gastroenterol, 1999 ;94(12): 3589

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部